Introduction
Textile-based nonwoven drug delivery systems present unique properties, including high surface area, and drug loading capacity, fabrication ease and options for surface modifi cations make them attractive alternatives to current drug delivery devices [26] . The principle of electrospinning process is to use electrostatic force as the main driving power for fi bre formation [24] . One of the obvious advantages of the electrospinning process is the highly porous structure of electrospun fi bre mats, which exhibits much greater surface area and possibility of functionalization [13, 25] . More specifi cally, incorporation of cyclodextrins (CDs) into electrospun nanofi brous materials is considered as potential candidates for functional textile applications [14] .
Topical administration of active pharmaceutical substances is in principle favourable for rapid onset of drug action and ready accessibility [12] . This administration could be very effi cient and useful in the treatment of acute pain related conditions [26] . The clinical effi cacy of a topically applied drug depends not only on its pharmacologic properties but also on the drug availability at the target site [15] . Theoretically, topically applied NSAIDs could act directly within the area of injury, without systemic activity, and reduce the infl ammatory reaction [8] .
Naproxen (NAP) (Fig. 1a) is a propionic acid derivative and is a type of non-steroidal anti-infl ammatory drug commonly administered for the treatment of pain, infl ammation and fever [9, 11] .
CDs are one of the most promising materials for the development of products with advanced properties due to inclusion complex formation ability with a wide variety of substances [16] . CDs have been explored extensively as additives in the pharmaceutical industry due to their ability to host and solubilize hydrophobic
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Fourier transform infrared spectroscopy (FT-IR)
FT-IR transmission spectra were recorded using a PerkinElmer FTIR spectrometer. Pure drug, β-CD, HP-β-CD, NAP/β-CD and NAP/HP-β-CD inclusion complexes were previously mixed thoroughly with potassium bromide separately. Scans were obtained in a spectral range from 650 to 4000 cm 1 with a resolution of 1 cm 1 .
The preparation of electrospinning solutions
10% (w/w) of TPU stock solutions was prepared by dissolving TPU granules in N,N dimethylformamide at room temperature. The NAP, NAP/β-CD and NAP/HP-β-CD loaded TPU solutions were obtained by dispersing the NAP and CD inclusion complex powders in stock solutions. NAP concentrations were fixed at 10% with respect to polymer weight for all solutions.
The weight of the inclusion complexes were calculated based on the amount of NAP (10% w/w polymer ).
Electrospinning
Electrospinning of the polymer solutions was carried out by a set-up consisting of a syringe (10 ml) and needle (2.5-cm long, 22 gauges, flat tip), a ground electrode and a high-voltage supply (Simco, MP Series CM5 30 P, Charging Generator Output 30 kV DC). Polymer solutions were electrospun at a voltage of 13 kV, and a tip-to-collector distance of 20 cm with a feeding rate of 1 ml/h. A grounded stationary rectangular metal collector covered with a piece of aluminium foil was used for the nanofibre deposition.
Scanning electron microscopy (SEM) and thickness measurements
The morphology of NAP, β-CD, HP-β-CD, NAP/β-CD and NAP/HP-β-CD inclusion complexes and the electrospun TPU nanofibres was characterized using SEM (FEI Quanta 250FEG). Each sample was coated with a thin film of gold using an EMITECH K550X ion sputtering device. Fibre diameters were determined by using Image J software. Fibre diameters were measured by using SEM images by drawing straight lines perpendicular to the fibre axis. The pixel values of the lines were converted to diameter values. Fifty measurements were carried out from the different parts of each sample. The thickness of the nanofibrous mats was measured at eight points by a Mitutoyo digital micrometer at guest molecules including drugs [16, 23] . β-CD, which is illustrated in Fig. 1b , is the most commonly used CD due to the cavity size, availability and low cost [5] . Apart from parent CDs its alkylated derivatives, e.g. 2-hydroxy propyl-β-CD (HP-β-CD) (Fig  1c) , have also attracted growing interest due to their improved complexation efficiency, greater water solubility and less toxicity [3] . Inclusion complex formation with CDs is an approach to improve the aqueous solubility via molecular encapsulation of the drug within the cavity of the more soluble CD molecule [2, 21] . Molecular weight and solubility parameters of β-CD and HP-β-CD were given in Table 1 .
The objective of this study was to develop and characterize a novel electrospun nonwoven material loaded with NAP-CD inclusion complexes to obtain immediate release due to higher solubility enhancement of NAP by β-CD and HP-β-CD inclusion complex formation for topical treatment of pain-associated conditions with acute minor injuries. In this scope, NAP-CD inclusion complexes were prepared (Fig 2) and incorporated into thermoplastic polyurethane (TPU) nanofibrous mats via electrospinning process.
Experimental

Materials
TPU (Pellethane 2103-80AE, based on 4,4-methylene bisphenylene isocyanate, polytetramethyleneoxide and 1,4 butanediol) was received from Velox (Lubrizol Advanced Materials). NAP, N,N-dimethylformamide (≥99%), potassium dihydrogen phosphate(98-100.5%) and sodium hydroxide (NaOH) (99.99%) were purchased from Sigma-Aldrich. β-CD and HP-β-CD were purchased from Wacker Chemie AG.
The preparation of solid NAP/β-CD and HP β-CD inclusion complex
NAP and CDs at a molar ratio of 1:1 were dissolved in enough equal volume of ethanol and ultra pure water, respectively, and then the two solutions were mixed and stirred at room temperature for 1 hour. Dried complexes were obtained by lyophilisation in a freeze dryer, where samples were frozen at -80°C for approximately 48 h followed by drying at 0.05 mbar for 24 h. The powders obtained were stored in gas-tight bottles at room temperature until use.
X-ray diffraction (XRD)
X-ray powder diffraction patterns were determined for pure drug, β-CD, HP-β-CD, NAP/β-CD and NAP/HP-β-CD inclusion 3. Results and discussion
The XRD patterns of the pure NAP, pure β-CD and HP-β-CD, NAP/β-CD and NAP/HP-β-CD inclusion complexes were recorded to investigate the possible differences in the crystallinity of the structures (Fig. 2) . In the X-ray diffractogram of pure NAP powder (Fig. 2e) , sharp peaks at a diffraction angle of 2θ 6.5, 12.5, 13, 16.5, 18, 19, 20, 22, 23.5, 27 and 28.2 are present, and it suggests that the drug is present as a crystalline material [1] . The X-ray diffractogram of NAP/HP-β-CD powder (Fig.2c) showed with respect to the diffraction patterns of the starting materials, the broadening, disappearance and intensity diminution of some NAP diffraction peaks, especially those situated at 7, 19 and 29° (-2θ). These findings suggest the presence of a new solid phase with a lower degree of crystallinity, which could be originated by the molecular interaction of the host HP-β-CD and the guest NAP. NAP/β-CD (Fig. 2a) presented a diffraction pattern completely diffused, with the disappearance of the characteristic peaks of NAP and β-CD, reflecting the amorphous nature of this binary system. This is a direct proof of the formation of a new solid phase and can be considered as a very probable indication of the inclusion complex formation between NAP and β-CD in the solid state [7] .
Fourier transform infrared spectroscopy (FT-IR)
The FT-IR spectra of NAP-CD complexes were compared with the pure drug, β-CD and HP-β-CD powder. NAP peaks 0.001 mm accuracy and average thickness is calculated from these measurements.
Statistical analysis
All results were expressed as mean ± SD. Data were analysed by one-way ANOVA followed by Tukey HSD post hoc test. Differences of P < 0.05 were considered statistically significant.
In vitro drug release studies
Total immersion method was used to study the release characteristics of the drug from the NAP-loaded electrospun TPU fibre mats. The samples (in dimension of 3 × 3 cm) were accurately weighed and immersed in a glass bottle containing phosphate buffer pH 7.4 USP and the bottles were incubated in a horizontal incubation shaker (Thermo-Scientific MaxQ6000) at 37 ± 0.5°C and 60 rpm. At a specified immersion period ranging between 0 and 120 h ( 5 days), 0.5 ml of the sample was taken out at selected times and an equal volume of medium was returned to the system after withdrawal. The samples were then assayed spectrophotometrically at 263 nm. The experiments were carried out in triplicate. The release of the drug from the samples was reported as the cumulative release of the drug as a function of the immersion period. The calibration curve of NAP was prepared by using stock solutions in 22 different concentrations between 0.625 and 50 µg/ml. It showed linearity and acceptability with R 2 ≥ 0.99. The maximum absorbance measurement results were adapted to this calibration curve. The morphology of electrospun nanofibres of pure NAP loaded, NAP/β-CD and NAP/HP-β-CD inclusion complex loaded TPU nanofibres was investigated by SEM imaging. The representative images of SEM micrographs are given in Fig. 5 . Based on the SEM images (Fig. 5a-c) , bead-free nanofibres with diameter variation were obtained from all three TPUbased nanofibrous samples. NAP-loaded nanofibres were more uniform compared with the NAP/β-CD and NAP/HP-β-CD inclusion complex loaded TPU nanofibres. Especially, there are several slubs along the NAP/β-CD inclusion complex loaded nanofibres axis. We hypothesize that these slubs would be preferably the result of the incorporation of the inclusion complexes to the fibres. After release tests, SEM images of NAP/β-CD and NAP/HP-β-CD inclusion complex loaded TPU nanofibres were completely different from their initial state.
Complete disappearance of the fibre uniformity and roughening defects of these irregular fibres was also possibly associated with the dissolution of the inclusion complexes, which were primarily incorporated into the fibre axis. This result also supports the hypothesis of the incorporation of the inclusion complexes to the fibres.
Mean diameter of the fibres and mean thickness of the electrospun mats were summarized in Table 2 . There was a statistically significant difference between the mean diameters of three groups as determined by one-way ANOVA (F(2,147) = 8.292, p = .000). A Tukey post hoc test revealed that the mean diameter of the TPU nanofibres was statistically significantly higher after loading NAP/β-CD (879.68 ± 159.12 nm, p = 0.000) or NAP/HP-β-CD (834.34 ± 215.37 nm, p = 0.016) inclusion complexes compared with the pure NAP loading (723.50 ± 212.32 nm). There were no statistically significant differences observed in region of 800-2000 cm −1 includes peaks at 1729, indicating the -C=O (carbonyl) stretch, peak at 1630 cm −1 due to ʋ(C-C) modes of the aromatic groups [6] and the peak at 1228 cm -1 , indicative of the -O-stretch [9, 11, 17] and 1394 cm −1 due to CH 3 bending [10] . The vibration modes detected at 1026 and 857 cm −1 correspond to C-O-C bonds in NAP [27] . In the case of inclusion complexes, in particular, the characteristic carbonyl-stretching band of drug appeared at 1729 and shifted to 1728 cm −1 for NAP/β-CD and NAP/HP-β-CD complexes, respectively, along with significantly reduced intensity of the same band. Characteristic absorption bands of the pure drug at 1604 cm [20] are maintained in NAP/β-CD with an evident reduction in intensity. Changes in the characteristic bands of pure drug confirm the existence of the complex as a new compound with different spectroscopic bands [22] 3.3. Scanning-electron microscope (SEM) and thickness measurements Figure 4a -e presents the SEM images of NAP, β-CD, HP-β-CD and the corresponding 1:1 NAP/β-CD, NAP/HP-β-CD inclusion complexes, respectively. The SEM of NAP appeared as of distorted tubular shapes and sizes, and tended to form aggregates (Fig. 2a) . HP-β-CD is observed as "shrinked" cylindrical spheres (Fig. 2c) , whereas β-CD appeared as irregularly shaped crystals (Fig. 2b) . In contrast, it was not possible to recognize individual component particles in the SEM image of the NAP/β-CD and NAP/HP-β-CD complex (Fig.  2d-e between the diameters of NAP/β-CD and NAP/HP-β-CD groups (p = 0.486). In case of mean thickness, similar to mean diameters, there was a significant effect of NAP, NAP/β-CD or NAP/HP-β-CD loading on the mat thickness at p < 0.05 level of the three conditions [F(2,69) = 32.34, p= 0.000)].
The release characteristics of NAP from NAP, NAP/β-CD and NAP/HP-β-CD inclusion complex loaded electrospun TPU mats are shown in Fig. 6a -c. The release rates were investigated in PBS of pH 7.4 at 37°C. Pure NAP loaded fibres released about 54% of its drug content within 24 hours and reached about 94% of its drug content within 96 hours (4 days). NAP/ HP-β-CD inclusion complex loaded fibres showed the fastest release compared with the NAP/β-CD inclusion complex and NAP-loaded fibres. It released about 50% of its NAP content within 30-45 minutes, 80% of its NAP content between 1 and 1.5 hour and reached about 98% of its NAP content after 4 hours, whereas NAP/β-CD inclusion complex loaded fibres released about 50% of its NAP content between 1.5 and 2 hour, 80% of NAP content after 8 hour and completed its release after 30 hours. The release profiles revealed that NAP/ HP-β-CD inclusion complex loaded TPU nanofibrous system has more than two times higher release rate than NAP/β-CD inclusion complex loaded TPU system. NAP/β-CD-TPU system has more than two times higher release rates than pure NAP loaded TPU system. As hydrophilic CDs can modify the rate of drug release [22] , in this study it was shown that drug release rates from electrospun fibrous systems can be modified by using β-CD or HP-β-CD drug inclusion complex formation. To show the release characteristics of NAP or NAP-CD complex loaded electrospun nanofibrous systems, the release profiles for 8, 48 and 120 hours were given separately.
Conclusions
NAP and its β-CD, HP-β-CD inclusion complexes were successfully prepared by freeze-drying process. Prepared NAP/β-CD and NAP/HP-β-CD inclusion complexes were loaded to electrospun TPU fibres separately and their release characteristics were compared with pure NAP loaded TPU fibres. NAP/β-CD and NAP/HP-β-CD inclusion complexes loading have a significant effect on the resultant fibre diameter when compared with the pure NAP loading. It was seen that NAP release rate can be increased by using CD complexes because of the interaction ability of β-CD and HP-β-CD with poorly-water soluble drugs to increase their apparent solubility [4] . Overall, combining highly porous structure of the electrospun fibres, NAP-inclusion complex loaded TPU electrospun nanofibres could be used as textile-based drug delivery systems for acute pain treatments that can release the drug immediately. 
